once a week glp 1 agonist GLP-1 & GLP-1/GIP Weight Loss Effects ๐ฎ Frontiers | GLPโ1 receptor agonists
Description
Full dose or microdose
Shima Hadidchi, MD, in Apple Valley and Victorville, CA
The glp-1 agonists market is expected to reach US$ 118,926.1 billion by 2032, growing at a significant CAGR of 18.1% from 2026 to 2032.
Medicare is already spending billions on drugs like Ozempic, and Biden recently proposed expanding access to obesity treatments.
As we await prospective data, clinical practice should consider the difference between abrupt stop vs gradual taper when counseling patients about expectations after therapy
Beyond these metabolic benefits, accumulating evidence indicates that GLP-1RAs exert immunomodulatory effects, including suppression of pro-inflammatory cytokines, enhancement of regulatory T-cell function, and improvements in adipose tissue and gut-derived immune signaling
